Company Filing History:
Years Active: 2021-2025
Title: The Innovative Contributions of Romain Noel
Introduction
Romain Noel, an accomplished inventor based in Villeurbanne, France, has made significant strides in the field of pharmaceutical formulations. With a robust portfolio encompassing seven patents, his work focuses on developing injectable solutions that enhance the efficacy of insulin therapies.
Latest Patents
Among Romain Noel's latest innovations are two influential patents that enhance diabetes treatment options. The first patent introduces compositions in the form of injectable aqueous solutions that comprise amylin, an amylin agonist receptor, or an amylin analogue alongside a co-polyamino acid. This innovative solution is characterized by maintaining a pH between 6.0 and 8.0, specifically designed to omit basal insulin for which the isoelectric point is noted as being between 5.8 to 8.5. This formulation allows for the inclusion of prandial insulin, providing a more effective therapy for diabetes management.
The second significant patent features a physically stable injectable solution with a pH ranging from 6.0 to 8.0. This composition includes a basal insulin whose isoelectric point falls within the range of 5.8 to 8.5, combined with a co-polyamino acid that bears carboxylate charges and hydrophobic radicals. These advancements signify pivotal contributions to the precision and reliability of insulin administration.
Career Highlights
Romain Noel currently holds a position at Adocia, a biopharmaceutical company renowned for its innovative approaches to diabetes and other chronic diseases. His work has been instrumental in advancing the company's research and development efforts, especially in novel drug delivery systems.
Collaborations
Throughout his career, Romain has collaborated with esteemed colleagues, including You-Ping Chan and Alexandre Geissler. Their combined expertise has fostered an environment of innovation and shared knowledge, contributing to the successful development of new patents and solutions in diabetes care.
Conclusion
Romain Noel's contributions to the field of injectable insulin therapies showcase his dedication as an inventor. With his innovative patents addressing crucial aspects of diabetes management, he continues to pave the way for advancements that could improve the quality of life for many patients. His collaboration with Adocia and colleagues highlights the importance of teamwork in achieving impactful healthcare solutions.